Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup